PREVNAR - 13: payments to doctors
Payments that named PREVNAR - 13 as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.4M
- Providers
- 43,406
- Transactions
- 105,427
- Average per transaction
- $23
The per-transaction average — $23 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 43,406 providers the average total is $56, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $2,382,421 | 97.7% |
| Pfizer Pharmaceuticals LLC | $41,894 | 1.7% |
| PBG Puerto RICO LLC | $9,688 | 0.4% |
| Pfizer S.A. | $4,403 | 0.2% |
| Array Biopharma Inc | $40 | 0.0% |